Abstract. In the present study, we de��nstr�te th�t �,7-d�hy-de��nstr�te th�t �,7-d�hy-dr�xy-6-ger�nylfl�v�n�ne (DGF) �s�l�ted fr�� Amorpha fruticosa (A. fruticosa) �s � n�vel per�x�s��e pr�l�fer�t�r-�ct�v�ted recept�r (PPAR)α/γ du�l �g�n�st wh�ch ��y be used t� ��pr�ve �nsul�n sens�t�v�ty. The extr�ct fr�� A. fruticosa �ncre�sed the tr�nscr�pt��n�l �ct�v�ty �f b�th PPARα �nd PPARγ wh�ch w�s, �n p�rt, dr�ven by the �ct�ve �ngred�ent DGF. Tre�t�ent w�th DGF ��rkedly enh�nced the �d�p�genes�s �f 3T3-L1 pre�d�p�cytes, wh�ch w�s c��p�r�ble t� the effect �f the PPARγ �g�n�st, tr�gl�t�z�ne. In �dd�t��n, DGF w�s f�und t� enh�nce f�tty �c�d �x�d�t��n �nd gluc�se ut�l�z�t��n thr�ugh the du�l �ct�v�t��n �f PPARα/γ. In �dd�t��n tre�t�ent w�th DGF led t� �n ��pr�ve�ent �n �nsul�n sens�t�v�ty, result�ng �n enh�nced glucose uptake in muscle cells. The findings of our study data suggest th�t DGF ��y be used �s p�tent��l ther�peut�c �gent �n the tre�t�ent �f type 2 d��betes �nd rel�ted �et�b�l�c d�s�rders by enh�nc�ng gluc�se �nd l�p�d �et�b�l�s�.
Introduction
Type 2 d��betes �ell�tus (T2DM), wh�ch �cc�unts f�r >90% �f d��betes c�ses, �s � c����n �et�b�l�c d�se�se th�t �s ch�r�cter-�zed by the res�st�nce �f t�rget t�ssues t� �nsul�n st��ul�t��n (1) . T2DM �s usu�lly �ss�c��ted w�th hyperglyce���, dysl�p�de���, �bes�ty, hypertens��n, f�tty l�ver d�se�se, �ther�scler�s�s, cert��n types �f c�ncer �nd c�rd��v�scul�r d�se�ses (2) . The pept�de h�r��ne, �nsul�n, l�wers bl��d gluc�se levels by f�c�l�t�t�ng gluc�se upt�ke, ���nly �nt� skelet�l �uscle �nd f�t t�ssue, �nd by �nh�b�t�ng end�gen�us gluc�se pr�duct��n �n the l�ver; �nsul�n res�st�nce �ccurs when � n�r��l d�se �f the h�r��ne �s �nc�p�ble �f el�c�t�ng these �et�b�l�c resp�nses (3) . Mult�ple defects �n �ntr�cellul�r events, �nclud�ng �n ��p��r�ent �f the �nsul�n s�gn�l�ng �x�s, d�srupt gluc�se �et�b�l�s� �nd reduce glyc�gen synthes�s, thus c�ntr�but�ng t� �nsul�n res�st�nce (4) (5) (6) .
Rel�ev�ng �nsul�n res�st�nce h�s been c�ns�dered � pr���s�ng �ppr��ch t� the tre�t�ent �f T2DM (7) . Thiazolidinediones (TZDs) and fibrates are some of the most c����nly used �ed�c�t��ns �n the tre�t�ent �f T2DM, hyperl�p�de��� �nd �nsul�n res�st�nce. These drugs b�nd t� �nd �ct�v�te per�x�s��e pr�l�fer�t�r-�ct�v�ted recept�rs (PPARs), wh�ch results �n the upregul�t��n �f sever�l genes �nv�lved �n gluc�se �nd l�p�d �et�b�l�s� (8) . The PPAR f���ly, bel�ng�ng t� the nucle�r h�r��ne recept�r f���ly, c�ns�sts �f 3 �s�f�r�s, PPARα, PPARβ/δ �nd PPARγ (9) . PPARγ �s ���nly expressed �n �d�p�se t�ssue �nd v�scul�r t�ssue/��cr�ph�ges (10) , �nd �s present �n �uscle �nd β cells �t l�w levels (11) ; �t �ffects genes �nv�lved �n l�p�d synthes�s �nd st�r�ge, �nd gluc�se h��e�st�s�s. It �s the funct��n�ng recept�r f�r TZDs, �nclud�ng r�s�gl�t�z�ne �nd p��gl-�t�z�ne (8) . PPARα �s pred���n�ntly expressed �n the l�ver (12) �nd st��ul�tes l�p�d c�nsu�pt��n by enh�nc�ng the express��n �f f�tty �c�d �x�d�t��n genes, result�ng �n the ��el��r�t��n �f hyperl�p�de��� (13) . PPARα agonists, including fenofibrate have been sh�wn t� exert p�tent effects by reduc�ng pl�s�� tr�glycer�de levels (14) . The d�st�nct �et�b�l�c effects �f PPARα �nd PPARγ �g�n�sts �n �nsul�n sens�t�v�ty �nd l�p�d �et�b�l�s� h�s enc�ur-�ged the devel�p�ent �f n�vel drugs wh�ch t�rget b�th PPARα �nd PPARγ (1�-17) . It h�s been pr�p�sed th�t the du�l �ct�v�t��n �f PPARα �nd PPARγ ��y gu�r�ntee ��re des�r�ble effects w�th l���ted �dverse effects (1�-17) . A nu�ber �f PPARα/γ du�l agonists have been identified and tested in obese and insulinres�st�nt �nd�v�du�ls (18, 19) ; h�wever, the ��j�r�ty �f these drugs h�ve been sh�wn t� h�ve unexpected s�de-effects, �nclud�ng he�rt f��lure, ren�l f��lure, ur�n�ry c�ncer �nd �ne��� (18, 19) . Theref�re, the devel�p�ent �f n�vel PPARα/γ du�l �g�n�sts w�th few �dverse effects �s urgently requ�red.
Amorpha fruticosa (A. fruticosa) (Legu��n�s�e) h�s been �ppl�ed tr�d�t��n�lly �n the tre�t�ent �f hypertens��n, he��t���s �nd c�ntus��ns �n Ch�n�, J�p�n �nd K�re�. Prev��us stud�es �n th�s pl�nt h�ve rep�rted � nu�ber �f phen�l�c c��p�unds, 5,7-Dihydroxy-6-geranylflavanone improves insulin sensitivity through PPARα/γ dual activation (20, 21) . In �ur prev��us stud�es, we de��nstr�ted the ther�peut�c p�tent��l �f ���rph�st�lb�l �s�l�ted fr�� A. fruticosa �n �et�b�l�c d�s�rders thr�ugh the du�l �ct�v�t��n �f PPARα/γ �n 3T3-L1 cell syste�s �nd �n���l ��dels (22, 23) . In the present study, we identified another active ingredient, 5,7-dihydroxy-6-geranylflavanone (DGF; chemical structure shown in Fig. 1 ), �s�l�ted fr�� A. fruticosa wh�ch pr���tes the du�l �ct�v�t��n �f PPARα/γ �nd expl�red �ts ph�r��c�l�g�c�l pr�pert�es.
Materials and methods
Cell culture and chemicals. Adipocyte differentiation. Ad�p�cyte d�fferent��t��n w�s �nduced by tre�t�ng the cells w�th d�fferent��t��n �ed�u� (DM) c�nt��n�ng h�r��n�l c�ct��l (10 µg/�l �nsul�n, 1 µM dex�-�eth�s�ne �nd 0.� �M 3-�s�butyl-1-�ethylx�nth�ne) w�th 10% FBS �n DMEM f�r 48 h bef�re the cells were sw�tched t� � ���nten�nce �ed�u� w�th 10% FBS �nd 10 µg/�l �nsul�n. After �n �dd�t��n�l 48 h, the �ed�u� w�s repl�ced w�th 10% FBS-DMEM. There�fter, the �ed�u� w�s ch�nged every 2 d�ys. The test drugs were �d��n�stered �t the �n�t��t��n �f d�fferent��t��n �nd �t every �ed�u� ch�nge f�r 8 d�ys. The l�p�d �ccu�ul�t��n �n the cells w�s detected by O�l Red O st��n�ng. Ligand binding assay. The L�nth�Screen™ TR-FRET PPAR c��pet�t�ve b�nd�ng �ss�y (Inv�tr�gen) w�s perf�r�ed �cc�rd�ng t� the ��nuf�cturer's �nstruct��ns (24) . In br�ef, � ��xture �f � ng glut�th��ne S-tr�nsfer�se fused t� the PPAR l�g�nd-b�nd�ng d����n (GST-PPAR-LBD), � nM Tb-GST �nt�-b�dy, � nM Flu�r��ne P�n-PPAR Green, �nd ser��l d�lut��ns of DGF (≤100 µM) was added to the wells of black 384-well pl�tes t� � t�t�l v�lu�e �f 18 �l. F�ll�w�ng 2 h �f �ncub�t��n �n the d�rk, the FRET s�gn�l w�s �e�sured by exc�t�t��n �t 340 nm and emission at 520 nm using the Infinite ® M1000 ��cr�pl�te re�der (Tec�n Gr�up Ltd., Männed�rf, Sw�tzerl�nd).
Measurement of triglyceride content. Tr�glycer�de c�ntents were �e�sured us�ng the tr�glycer�de deter��n�t��n k�t (S�g��-Aldr�ch). F�ll�w�ng tre�t�ent, the d�fferent��ted 3T3-L1 �d�p�cytes were r�nsed tw�ce w�th PBS, scr�ped �n 200 µl �f s�l�ne s�lut��n (1�0 �M N�Cl, 2 �M EDTA, �0 �M s�d�u� ph�sph�te, pH 7.4), s�n�c�ted t� h���gen�ze the cell suspens��n �nd the t�t�l tr�glycer�de c�ntent w�s then �e�sured. The t�t�l tr�glycer�de c�ntent w�s deter��ned by �e�sur�ng the �ncre�se �n �bs�rb�nce �t �40 n� us�ng � ��cr�pl�te re�der (P�werW�ve XS; B��Tek Instru�ents Inc., W�n��sk�, VT, USA) �cc�rd�ng t� the ��nuf�cturer's �nstruct��ns. The results were expressed �s ��ll�gr��s �f tr�glycer�de per ��ll�gr�� �f cellul�r pr�te�n. The res�du�l cell lys�te w�s centr�fuged �t 12,000 rp� t� re��ve the f�tty l�yer, �nd w�s then �ss�yed f�r the �e�sure�ent �f the pr�te�n c�ntent us�ng � BCA pr�te�n �ss�y k�t (S�g��-Aldr�ch).
Measurement of glycerol-3-phosphate dehydrogenase (GPDH)
activity. GPDH �ct�v�ty w�s �e�sured us�ng � GPDH) �ct�v�ty �ss�y k�t (MK426; T�k�r� B�� Inc., Sh�g�, J�p�n). F�ll�w�ng tre�t�ent, the d�fferent��ted 3T3-L1 �d�p�cytes were r�nsed tw�ce w�th PBS, scr�ped �nt� 200 µl enzy�e extr�ct��n buffer (pr�v�ded w�th the k�t) �nd s�n�c�ted. GPDH �ct�v�ty w�s deter��ned �cc�rd�ng t� the decre�se �n NADH �ct�v�ty by �e�sur�ng the decre�se �n the �bs�rb�nce �t 340 n� us�ng � ��cr�pl�te re�der, �cc�rd�ng t� the ��nuf�cturer's �nstruct��ns.
Gene expression analysis. T�t�l RNA w�s �s�l�ted fr�� the 3T3-L1 �d�p�cytes �r HepG2 cells tr�nsfected w�th pcDNA3-hPPARα pl�s��d us�ng TRIz�l re�gent (Inv�tr�gen) �cc�rd�ng t� the ��nuf�cturer's �nstruct��ns. The RNA c�ncentr�t��n �f e�ch s��ple w�s deter��ned us�ng � spectr�ph�t��eter (N�n�dr�p 2000; Ther�� F�scher Scientific, Inc., W�l��ngt�n, DE, USA) �t 260 n�; the �ntegr�ty �f e�ch RNA s��ple w�s ev�lu�ted us�ng the Ag�lent 2100 B��An�lyzer (Ag�lent Techn�l�g�es, Inc., S�nt� Cl�r�, CA, USA). cDNA synthes�s w�s perf�r�ed us�ng 1 µg �f t�t�l RNA �n 20 µl w�th r�nd�� pr��ers �nd SuperScr�pt II reverse Myotube formation and western blot analysis. The C2C12 �y�bl�sts were cultured �n DMEM unt�l re�ch�ng 90% confluence. The cells were differentiated into myotubes w�th DMEM c�nt��n�ng 2% h�rse seru� f�r 4 d�ys, �nd then �ncub�ted f�r 16 h �n DMEM c�nt��n�ng 2% BSA �nd 10% FBS �n the �bsence �r presence �f 0.7� �M p�l��t�te t� �nduce �nsul�n res�st�nce. Subsequently, the DGF-tre�ted cells were st��ul�ted w�th 100 nM �nsul�n f�r 10 ��n. F�ll�w�ng st��u-l�t��n, the cells were w�shed tw�ce w�th PBS �nd h�rvested. F�r western bl�t �n�lys�s, �nt�b�d�es t� Akt (cs9272; 1:1,000), ph�sph�-Ser473 Akt (cs4060; 1:1,000), �nsul�n recept�r (IR) β (cs3020; 1:1,000), ph�sph�-Tyr113�/1136 �nsul�n gr�wth f�ct�r (IGF)-1Rβ/Tyr11�0/11�1 IRβ (cs3024; 1:1,000) were used (Cell S�gn�l�ng Techn�l�gy, Beverly, MA, USA).
2-NBDG glucose uptake assay. The �y�tubes, wh�ch were �bt��ned fr�� the �b�ve-�ent��ned pr�cedures, were st��u-l�ted w�th 100 nM �nsul�n f�r 1 h. F�ll�w�ng �nsul�n st��ul�t��n, the �y�tubes were �ncub�ted w�th �0 µM 2-NBDG (Inv�tr�gen) f�r 1� ��n �nd then w�shed w�th PBS 3 t��es t� re��ve free 2-NBDG. The fluorescence intensity of the cells containing 2-NBDG was measured using the Infinite M1000 microplate re�der (Tec�n Gr�up Ltd.) w�th exc�t�t��n �t 48� n� �nd e��s-s��n �t �3� n�.
Statistical analysis. D�t� �re expressed �s the �e�ns ± SD. D�fferences between the �e�n v�lues �n the 2 gr�ups were �n�lyzed us�ng �ne-w�y �n�lys�s �f v�r��nce (ANOVA). A v�lue of P<0.05 was considered to indicate a statistically significant d�fference.
Results

Dual activation of PPARα/γ transcriptional activity by A. fruticosa.
T� expl�re the ph�r��c�l�g�c�l pr�pert�es �f A. fruticosa, we ex���ned the effects �f A. fruticosa �n the tr�nscr�pt��n�l �ct�v�t��n �f PPARs. As sh�wn �n F�g. 2A �nd B, tre�t�ent w�th the extr�ct �f A. fruticosa led t� �n �ncre�se �n PPARα-�nd PPARγ-rep�rter gene �ct�v�t�es �n � d�se-dependent ��nner; h�wever, �t h�d � ��n���l effect �n the tr�nscr�pt��n�l �ct�v�-t��n �f PPARδ (F�g. 2C). In �dd�t��n, tre�t�ent w�th A. fruticosa extr�ct ��rkedly enh�nced the �d�p�cyte d�fferent��t��n �f the 3T3-L1 cells, �s sh�wn by O�l Red O st��n�ng (F�g. 2D), wh�ch w�s �cc��p�n�ed by �n �ncre�se �n the express��n �f �d�p�cyte ��rker genes, �nclud�ng CCAAT-enh�ncer-b�nd�ng pr�te�n (C/ EBP)α, PPARγ, adipocyte protein 2 (aP2), resistin, adiponectin, �nd gluc�se tr�nsp�rter type 4 (GLUT4) (F�g. 2E). These results str�ngly �nd�c�te the presence �f � n�vel PPARα/γ �g�n�st �n the fru�t extr�ct �f A. fruticosa.
DGF is a novel PPARα/γ dual activator.
As the PPARα/γ-rep�rter gene �ct�v�t�es �nd �d�p�cyte d�fferent��t��n were ��rkedly enh�nced by the extr�ct �f A. fruticosa, we w�shed t� �dent�fy the �ct�ve �ngred�ents �f A. fruticosa. Thus, we �s�l�ted and identified 5 compounds from A. fruticosa �nd ev�lu�ted the�r �ct�v�t�es �n PPARα/γ tr�nscr�pt��n�l �ct�v�t��n. As shown in Table ΙΙ , although amorphastilbol exhibited the most p�tent pr���t�ng effect �n PPARα/γ tr�ns�ct�v�t��n, DGF �ls� h�d � s���l�r effect. The �ther c��p�unds, 4,4'-d��e-thoxy-2'-hydroxychalcone, 4' ,7-dimethoxy-5-hydroxyisoflavone �nd 12α-hydr�xy-α-t�x�c�r�l, exerted we�ker effects th�n th�se �f ���rph�st�lb�l �nd DGF. S�nce the ph�r��c�l�g�c�l pr�pert�es �f ���rph�st�lb�l h�ve �lre�dy been rep�rted (22), T�ble II. Effects �f the c��p�unds fr�� A. fruticosa �n PPARα/γ tr�nscr�pt��n�l �ct�v�ty. �n th�s study, we f�cused �n the pr�pert�es �f DGF. As sh�wn �n F�g. 3A �nd B, tre�t�ent w�th DGF led t� �n �ncre�se �n b�th PPARα-�nd PPARγ-rep�rter gene �ct�v�t�es �n � d�se-dependent ��nner. H�wever, DGF exerted � ��n���l effect �n PPARδ tr�nscr�pt��n (F�g. 3C) �nd n� detect�ble effect �n ret�n��d X recept�r (RXRα) w�s �bsrved (F�g. 3D). The DGF b�nd�ng �ff�n�t�es t� PPARα �nd PPARγ were we�ker th�n th�se �f the p�s�t�ve c�ntr�ls, GW�01�16 �nd TRO (F�g. 3E), wh�ch �s �n �gree�ent w�th the we�k �b�l�ty �f DGF t� �ct�v�te the tr�nscr�pt��n �f PPARα/γ �n c��p�r�s�n t� th�t �f the p�s�-t�ve c�ntr�l (F�g. 3A �nd B).
Tr�ns�ct�v�t��n (f�ld) -----------------------------------------
DGF upregulates specific genes involved in both adipocyte differentiation and fatty acid oxidation. T� ev�lu�te the p�tent��l effects �f DGF �n �d�p�genes�s, 3T3-L1 pre�d�p�cytes were d�fferent��ted f�r 8 d�ys �n the presence �f DGF. As sh�wn �n F�g. 4A �nd B, tre�t�ent w�th DGF �nduced � ��rked �ncre�se �n l�p�d �ccu�ul�t��n �n the d�fferent��ted �d�p�cytes, wh�ch w�s c��p�r�ble t� the effects �f TRO. T� further ch�r�cter�ze the �d�p�gen�c p�tent��l �f DGF, the cellul�r tr�glycer�de c�ntent �nd GPDH enzy�e �ct�v�ty were �e�sured. The tr�glycer�de c�ntent �n the d�fferent��ted �d�p�cytes w�s �ls� �ncre�sed by DGF tre�t�ent up t� 1.�-f�ld (F�g. 4C); th�s �bserv�t��n w�s �n �cc�rd�nce w�th the result th�t DGF �nduced l�p�d dr�plet �ccu�ul�t��n �n �d�p�cytes, �s sh�wn �n Fig. 4A . In addition, GPDH activity was significantly enhanced by DGF tre�t�ent (F�g. 4D). T�ken t�gether, these results str�ngly supp�rt the n�t��n th�t DGF pr���tes the �d�p�cyte d�fferent��t��n �f 3T3-L1 cells. As �d�p�genes�s �s g�verned by the �ncre�sed express��n �f v�r��us tr�nscr�pt��n f�ct�rs �nd adipocyte-specific genes (25), we examined the effects DGF on the express��n �f �d�p�gen�c tr�nscr�pt��n f�ct�rs �nd ��rker genes �n the d�fferent��ted �d�p�cytes. F�ll�w�ng the �nduct��n �f �d�p�cyte d�fferent��t��n �n the presence �f DGF, the �RNA levels �f C/EBPα, PPARγ, aP2, adiponectin �nd resistin were �e�sured by qPCR. In the DGF-tre�ted �d�p�cytes, the �RNA levels �f these genes were ��rkedly �ncre�sed c��p�red t� the�r levels �n the �bsence �f DGF (F�g. 4E). In �dd�t��n, tre�t�ent w�th DGF �nduced �n �ncre�se �n the �RNA level �f GLUT4, wh�ch �s resp�ns�ble f�r �nsul�n-�ed��ted gluc�se upt�ke (26) , �nd�c�t�ng th�t the �nsul�n sens�t�v�ty �f �d�p�se t�ssue ��y be enh�nced by DGF tre�t�ent. Subsequently, we examined the effects of DGF on fatty acid oxidation to confirm �ts PPARα �g�n�st�c effect. In the HepG2 cells tr�nsfected w�th the PPARα �verexpress��n vect�r, the express��n levels �f tw� d�fferent PPARα t�rget genes �nv�lved �n β-�x�d�t��n, c�rn�t�ne p�l��t�yltr�nsfer�se 1α (CPT1α) �nd �cyl-C�A �x�d�se 2 (ACO2), were �ncre�sed by DGF tre�t�ent (F�g. 4F), supp�rt�ng the hyp�thes�s th�t DGF pr���tes f�tty �c�d �x�d�t��n thr�ugh the �ct�v�t��n �f PPARα.
DGF improves insulin sensitivity. T� further �scert��n the positive effects of DGF on insulin sensitivity, we first examined gluc�se upt�ke �n C2C12 �y�tubes under n�r��l c�nd�t��ns. As sh�wn �n F�g. �A, gluc�se upt�ke �n C2C12 �y�tubes �n the absence or presence of insulin was significantly enhanced by DGF tre�t�ent under n�r��l c�nd�t��ns. C�rresp�nd�ngly, tre�t�ent w�th DGF �ls� enh�nced the �nsul�n-�nduced ph�s-ph�ryl�t��n �f IR �nd Akt under n�r��l c�nd�t��ns (F�g. �C). We then ex���ned the effects �f DGF �n gluc�se upt�ke under p�l��t�te-�nduced �nsul�n-res�st�nt c�nd�t��ns. DGF enh�nced gluc�se upt�ke under �nsul�n-res�st�nt c�nd�t��ns �s well (F�g. �B). The effects �f DGF �n �nsul�n sens�t�v�ty under �nsul�n-res�st�nt c�nd�t��ns were further c�nf�r�ed by the elev�ted ph�sph�ryl�t��n levels �f these d�wnstre�� pr�te�ns �n �nsul�n s�gn�l�ng (F�g. �D). All these results suggest th�t the enh�nce�ent �f �nsul�n sens�t�v�ty by DGF �s �ed��ted by the �nsul�n-�nduced �ct�v�t��n �f the IR-Akt s�gn�l�ng �x�s �nd enh�nced gluc�se upt�ke.
Discussion
T2DM �nd rel�ted �et�b�l�c d�se�ses p�se � ser��us he�lth c�ncern �n ��dern s�c�et�es. We h�ve recently rep�rted th�t ���rph�st�lb�l �s�l�ted fr�� A. fruticosa exerts beneficial effects �n gluc�se �nd l�p�d �et�b�l�s� by select�vely �ct�-v�t�ng b�th PPARα �nd PPARγ, thus ��el��r�t�ng �et�b�l�c d�s�rders w�th�ut be�ng �ss�c��ted w�th �ny severe �dverse re�ct��ns th�t h�ve been �bserved f�r �ther PPAR �g�n�sts, such �s we�ght g��n �nd hep�t��eg�ly (22) . In th�s study, we de��nstr�ted th�t DGF, �s �n�ther n�vel PPARα/γ du�l �g�n�st �s�l�ted fr�� A. fruticosa, pr���ted �d�p�genes�s thr�ugh the upregulation of adipocyte specific marker gene expression, and improved insulin sensitivity. However, the binding affinit�es �f DGF t� b�th PPARα (>2� µM) �nd PPARγ (9.7 µM) were �uch we�ker th�n th�se �f ���rph�st�lb�l; the b�nd�ng affinities of amorphastilbol to both PPARα �nd PPARγ were rep�rted �s 1.� µM �nd 0.84 µM, respect�vely (22) . Alth�ugh �ts b�nd�ng �ff�n�t�es t� PPARα/γ were �uch we�ker th�n those of amorphastilbol, DGF significantly increased their tr�nscr�pt��n�l �ct�v�t�es, wh�ch resulted �n the upregul�t��n of adipocyte specific marker gene expression and the improve�ent �f �nsul�n sens�t�v�ty, �nd�c�t�ng th�t DGF �s �ne �f the �ct�ve �ngred�ents �f A. fruticosa w�th �nt�-d��bet�c pr�pert�es. It h�s been de��nstr�ted th�t r�s�gl�t�z�ne, � full �g�n�st �f PPARγ, �s �ss�c��ted w�th �n �ncre�sed r�sk �f he�rt �tt�cks, wh�ch p�tent��lly l���ts �ts �ppe�l �nd further cl�n�c�l use, �n sp�te �f �ts p�tent ��pr�ve�ent �f gluc�se �et�b�l�s� (27) . H�wever, recently, FDA de��nstr�ted th�t there �s n� d�rect ev�dence f�r the c�rd��v�scul�r r�sk �f r�s�gl�t�z�ne �fter rev�ew�ng the results �f cl�n�c�l tr��ls (28) . In �dd�t��n, p��gl�t�z�ne, �n�ther PPARγ �g�n�st, �s less frequently �ss�c��ted w�th �ncre�sed c�rd��v�s-cul�r r�sk (29) . All these f�cts ��ply th�t PPARγ �ct�v�ty �tself ��y n�t be d�rectly �ss�c��ted w�th th�s c�rd��v�scul�r r�sk. Theref�re, the devel�p�ent �f n�vel p�rt��l PPAR �g�n�sts th�t �re structur�lly unrel�ted t� TZDs, p�rt�cul�rly r�s�gl�t�z�ne, re���ns �ppe�l�ng. Fr�� th�s p��nt �f v�ew, �t �s n�tew�rthy th�t ���rph�st�lb�l �nd DGF �s�l�ted fr�� A. fruticosa �re p�rt��l du�l �g�n�sts �f PPARα/γ �nd th�t the�r che��c�l structures �re un�que fr�� th�se �f TZDs. In �dd�t��n, ���rph�st�lb�l �nd DGF d� n�t �ffect hERG K + ch�nnel �ct�v�ty, wh�ch �s �ss�c��ted w�th c�rd��v�scul�r t�x�c�ty (d�t� n�t sh�wn). T�ken t�gether, these d�t� supp�rt, �n p�rt, the rel�t�ve s�fe use �f ���rph�st�lb�l �nd DGF w�th reg�rd t� c�rd��v�scul�r r�sk.
Insul�n res�st�nce �ccurs when � n�r��l level �f �nsul�n �s �nc�p�ble �f el�c�t�ng �ts �et�b�l�c resp�nses (3) �nd results fr�� �ult�ple �ntr�cellul�r defects, �nclud�ng �n ��p��r�ent �f the �nsul�n s�gn�l�ng �x�s (4-6). Our d�t� de��nstr�ted th�t DGF ��el��r�ted �nsul�n res�st�nce by �ct�v�t�ng the �nsul�n s�gn�l�ng �x�s, result�ng �n the enh�nce�ent �f gluc�se upt�ke (F�g. �A �nd B).
In c�nclus��n, �n th�s study, we de��nstr�te th�t DGF exerts beneficial effects on glucose and lipid metabolism, thus ��el��r�t�ng �et�b�l�c d�s�rders by select�vely �ct�v�t�ng b�th PPARα �nd PPARγ. These results str�ngly suggest th�t DGF �s �ne �f �ct�ve c��p�nents �f A. fruticosa w�th �nt�-d��bet�c �nd �nt�-�et�b�l�c pr�pert�es. Theref�re, �ur d�t� pr�v�de str�ngly supp�rt the further devel�p�ent �f A. fruticosa �nd �ts c��p�-nent DGF �s �nt�-�et�b�l�c �gents f�r the tre�t�ent �f gluc�se �nd l�p�d �bn�r��l�t�es, �s well �s �nsul�n res�st�nce.
